Prostate cancer vaccines in combination with additional treatment modalities

被引：15
|
作者：
Uhlman, Matthew A. [1 ]
Bing, Megan T. [1 ]
Lubaroff, David M. [1 ,2 ,3 ]
机构：
[1] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
来源：
IMMUNOLOGIC RESEARCH | 2014年 / 59卷 / 1-3期
关键词：
Prostate cancer; Immunotherapy; Cancer vaccines; Combination therapy; AUTOLOGOUS CELLULAR IMMUNOTHERAPY; SIPULEUCEL-T; IMMUNOSTIMULATORY PROPERTIES; ANTITUMOR-ACTIVITY; INCREASED SURVIVAL; RADIATION-THERAPY; ACID-PHOSPHATASE; DOUBLE-BLIND; PHASE-II; DOCETAXEL;
D O I：
10.1007/s12026-014-8532-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Immunotherapy has been investigated in both preclinical studies and clinical trials as a new therapy for prostate cancer. Vaccines, including those that utilize dendritic cells, viruses, or DNA, immunize against prostate-specific antigen and prostatic acid phosphatase. The vaccines have long been studied as monotherapy for the cancer, but increasingly more trials have been initiated in combination with other modalities. These include radiation, chemotherapy, and androgen deprivation therapy. This review describes and discusses the various combinations of vaccine immunotherapies.
引用
收藏
页码：236 / 242
页数：7
相关论文
共 50 条
  • [1] Prostate cancer vaccines in combination with additional treatment modalities
    Matthew A. Uhlman
    Megan T. Bing
    David M. Lubaroff
    Immunologic Research, 2014, 59 : 236 - 242
  • [2] Treatment modalities for localised prostate cancer
    Abu-Ghanem, Yasmin
    Madhavan, Subash Guru
    Kirby, Roger
    Challacombe, Ben
    TRENDS IN UROLOGY & MENS HEALTH, 2012, 3 (02) : 21 - 25
  • [3] Vaccines as Monotherapy and in Combination Therapy for Prostate Cancer
    Rotow, Julia
    Gameiro, Sofia R.
    Madan, Ravi A.
    Gulley, James L.
    Schlom, Jeffrey
    Hodge, James W.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2010, 3 (03): : 116 - 122
  • [4] Immunotherapy Vaccines for Prostate Cancer Treatment
    He, Jide
    Wu, Jialong
    Li, Ziang
    Zhao, Zhenkun
    Qiu, Lei
    Zhu, Xuehua
    Liu, Zenan
    Xia, Haizhui
    Hong, Peng
    Yang, Jianling
    Ni, Ling
    Lu, Jian
    CANCER MEDICINE, 2024, 13 (20):
  • [5] DNA vaccines for the treatment of prostate cancer
    Alam, Sheeba
    McNeel, Douglas G.
    EXPERT REVIEW OF VACCINES, 2010, 9 (07) : 731 - 745
  • [6] Neoadjuvant and adjuvant treatment modalities for prostate cancer
    Erkan, Erkan
    Toktas, Gokhan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (02): : 63 - 69
  • [7] Targeted nanomedicine modalities for prostate cancer treatment
    Cohen, Lital
    Livney, Yoav D.
    Assaraf, Yehuda G.
    DRUG RESISTANCE UPDATES, 2021, 56
  • [8] Dendritic cell vaccines for the treatment of prostate cancer
    Lehrfeld, Todd J.
    Lee, David I.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (06) : 576 - 580
  • [9] Tissue vaccines for prevention and treatment of prostate cancer
    Suckow, M. A.
    Hall, P.
    Hiles, M. C.
    2ND GLOBAL CONGRESS ON VACCINES, 2009, 1 (01): : 124 - 126
  • [10] Tissue Vaccines for Prevention and Treatment of Prostate Cancer
    Suckow, M. A.
    Hall, P.
    Hiles, M. C.
    VACCINE, 2008,
12345